Doctors group files legal petition urging USDA to require colorectal cancer warning labels on processed meat
Reports and Proceedings
Updates every hour. Last Updated: 26-Jun-2026 01:16 ET (26-Jun-2026 05:16 GMT/UTC)
To help protect Americans from colorectal cancer, which is now the leading cause of cancer death for people under 50, the Physicians Committee for Responsible Medicine filed a legal petition today urging the U.S. Department of Agriculture to require warning labels on processed meat and poultry products, such as bacon, deli meat, and hot dogs, which have been classified as “carcinogenic to humans” because of their link to colorectal cancer.
USC physician-scientist Mohamed Abou-el-Enein, MD, PhD, has found himself in a win-win situation: winning not one but two awards from the American Society of Gene + Cell Therapy (ASGCT), the leading professional organization in the field.
The first award celebrates Abou-el-Enein as a 2026 Outstanding New Investigator based on his contributions to the field of gene and cell therapy within the first 10 years of his career as an independent investigator.
The second, the 2026 Best of Molecular Therapy Award, honors a paper from his lab that demonstrates exceptional novelty, innovation and scientific significance. This year’s award recognizes “High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing” by first author Amaia Cadinanos-Garai. Additional authors are Christian L. Flugel, Anson Cheung, Enzi Jiang and Alix Vaissié from the Abou-el-Enein Lab and USC/Children’s Hospital Los Angeles (CHLA) Cell Therapy Program.
Researchers at the National Institutes of Health (NIH) have identified a novel, highly potent opioid that shows potential as a therapy for both pain and opioid use disorder. In a study published in Nature, the team observed the new drug’s effect in laboratory animals. They showed that it has high pain-relieving effects without causing respiratory depression, tolerance or other indicators of potential for addiction in humans.
A large multi-site study published in JAMA found that AI-powered ambient documentation technologies, or AI scribes, were associated with modest reductions in clinicians’ EHR use (13 minutes/day) and documentation time (16 minutes/day, ~10%), along with a slight increase in productivity. The benefits were most evident in high-frequency users, and are unlikely to fully explain prior reported improvements in burnout, highlighting the need for further research on how these tools reshape clinical workflows.